Peter Blume-Jensen, President and CEO at Acrivon Therapeutics, Inc. (ACRV), sold 1,713 shares at $2.01 ($3K) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Open-market sale of $3k ACRV by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 484 | $973 | 28.3% |
| 2 | $2.01 | 1,229 | $2K | 71.7% |
| Total | $2.01 avg | 1,713 | $3K | 100% |
| Filing → |